Global Dry Eye Syndrome Therapeutics Market Report to 2029 – Featuring Abbott, AbbVie, Allergan and AstraZeneca Among Others – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Dry Eye Syndrome Therapeutics Market Analysis by Product Type, by Disease Type, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The dry eye syndrome (DES) therapeutics market size is estimated to be USD 4,310 million in 2021 and is expected to witness a CAGR of 9.45% during the forecast period 2022-2029. The growing number of persons who get dry eyes, increasing healthcare costs, and a rise in the volume of R&

Full Story →